159 related articles for article (PubMed ID: 22936563)
1. Combined chemotherapy with gemcitabine and carboplatin for metastatic urothelial carcinomas in patients with high renal insufficiency.
Tanji N; Fukumoto T; Miura N; Yanagihara Y; Shirato A; Azuma K; Miyauchi Y; Kikugawa T; Shimamoto K; Yokoyama M
Int J Clin Oncol; 2013 Oct; 18(5):910-5. PubMed ID: 22936563
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.
Balar AV; Apolo AB; Ostrovnaya I; Mironov S; Iasonos A; Trout A; Regazzi AM; Garcia-Grossman IR; Gallagher DJ; Milowsky MI; Bajorin DF
J Clin Oncol; 2013 Feb; 31(6):724-30. PubMed ID: 23341513
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma.
Alva A; Daignault S; Smith DC; Hussain M
Invest New Drugs; 2014 Feb; 32(1):188-94. PubMed ID: 24318901
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas.
Tanji N; Ozawa A; Miura N; Yanagihara Y; Sasaki T; Nishida T; Kikugawa T; Ikeda T; Ochi T; Shimamoto K; Aoki K; Yokoyama M
Int J Clin Oncol; 2010 Aug; 15(4):369-75. PubMed ID: 20340038
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features.
Shannon C; Crombie C; Brooks A; Lau H; Drummond M; Gurney H
Ann Oncol; 2001 Jul; 12(7):947-52. PubMed ID: 11521800
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin.
Yumioka T; Honda M; Nishikawa R; Teraoka S; Kimura Y; Iwamoto H; Morizane S; Hikita K; Takenaka A
Int J Clin Oncol; 2020 Jan; 25(1):158-164. PubMed ID: 31520176
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma.
Tsuruta H; Inoue T; Narita S; Horikawa Y; Saito M; Obara T; Numakura K; Maita S; Satoh S; Tsuchiya N; Habuchi T
Int J Clin Oncol; 2011 Oct; 16(5):533-8. PubMed ID: 21431341
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy of paclitaxel, carboplatin and gemcitabine in patients who have received prior cisplatin-based chemotherapy].
Ito H; Aoki Y; Oyama N; Miwa Y; Akino H; Yokoyama O
Gan To Kagaku Ryoho; 2011 Mar; 38(3):481-4. PubMed ID: 21403460
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy.
Nogué-Aliguer M; Carles J; Arrivi A; Juan O; Alonso L; Font A; Mellado B; Garrido P; Sáenz A;
Cancer; 2003 May; 97(9):2180-6. PubMed ID: 12712469
[TBL] [Abstract][Full Text] [Related]
10. Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen.
Takahashi T; Higashi S; Nishiyama H; Segawa T; Nakamura E; Kinoshita H; Itoh N; Yamamoto S; Kamoto T; Habuchi T; Ogawa O
Jpn J Clin Oncol; 2006 Feb; 36(2):104-8. PubMed ID: 16418182
[TBL] [Abstract][Full Text] [Related]
11. Effects of Chemotherapy-Induced Neutropenia on Overall Survival in Patients With Unresectable or Metastatic Urothelial Carcinoma to Gemcitabine Plus Cisplatin Combination Chemotherapy.
Yamamoto K; Sasano T; Tsuji D; Ishizuka Y; Tokou U; Nakamichi H; Yoneda T; Shiokawa M; Yabe K
Ann Pharmacother; 2019 Jul; 53(7):690-696. PubMed ID: 30734587
[TBL] [Abstract][Full Text] [Related]
12. Low-dose maintenance gemcitabine-carboplatin chemotherapy could be an alternative to continuous standard chemotherapy for patients with metastatic urothelial carcinoma.
Mitsuzuka K; Yamashita S; Namiki S; Yamada S; Sato K; Saito H; Kaiho Y; Ito A; Nakagawa H; Arai Y
Int J Urol; 2014 Nov; 21(11):1114-9. PubMed ID: 24962105
[TBL] [Abstract][Full Text] [Related]
13. Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM).
Holmsten K; Jensen NV; Mouritsen LS; Jonsson E; Mellnert C; Agerbæk M; Nilsson C; Moe M; Carus A; Öfverholm E; Lahdenperä O; Brandberg Y; Johansson H; Hellström M; Maase HV; Pappot H; Ullén A
Eur J Cancer; 2020 Mar; 127():173-182. PubMed ID: 31648851
[TBL] [Abstract][Full Text] [Related]
14. Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium.
Hoschke B; May M; Seehafer M; Helke C
Int J Urol; 2004 Jul; 11(7):461-6. PubMed ID: 15242353
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.
De Santis M; Bellmunt J; Mead G; Kerst JM; Leahy M; Maroto P; Skoneczna I; Marreaud S; de Wit R; Sylvester R
J Clin Oncol; 2009 Nov; 27(33):5634-9. PubMed ID: 19786668
[TBL] [Abstract][Full Text] [Related]
16. [Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function].
Helke C; May M; Hoschke B
Aktuelle Urol; 2006 Sep; 37(5):363-8. PubMed ID: 17004181
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and cisplatin for advanced urothelial carcinomas: the Ehime University Hospital experience.
Ozawa A; Tanji N; Ochi T; Yanagihara Y; Kikugawa T; Yamaguchi A; Ikeda T; Shimamoto K; Aoki K; Toshino A; Yokoyama M
Int J Clin Oncol; 2007 Aug; 12(4):279-83. PubMed ID: 17701007
[TBL] [Abstract][Full Text] [Related]
18. Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.
Yoneyama T; Imai A; Hatakeyama S; Hashimoto Y; Koie T; Ohyama C
Int J Clin Oncol; 2015 Dec; 20(6):1179-84. PubMed ID: 26007690
[TBL] [Abstract][Full Text] [Related]
19. [Gemcitabine and cisplatin (GC) or gemcitabine and carboplatin (GCarbo) in patients with metastatic urothelial cancer].
Sumiyoshi T; Matsumoto K; Utsunomiya N; Segawa T; Muguruma K; Kawakita M
Hinyokika Kiyo; 2013 Jan; 59(1):1-6. PubMed ID: 23412116
[TBL] [Abstract][Full Text] [Related]
20. Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma.
Hurwitz ME; Markowski P; Yao X; Deshpande H; Patel J; Mortazavi A; Donadio A; Stein MN; Kelly WK; Petrylak DP; Mehnert JM
Clin Genitourin Cancer; 2018 Dec; 16(6):437-444.e6. PubMed ID: 30177237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
